Get the Stockscreener App
19.44
0.93%
0.18
After Hours:
19.41
-0.03
-0.15%
Vor Biopharma Inc stock is traded at $19.44, with a volume of 948.21K.
It is up +0.93% in the last 24 hours and up +20.75% over the past month.
Vor Biopharma Inc is a clinical-stage biopharmaceutical company focused on developing novel therapies for the treatment of autoimmune diseases. Its program, telitacicept, is a potential first- and best-in-class dual BAFF/APRIL inhibitor designed to suppress the signaling pathways that drive the maturation, proliferation, and survival of harmful B cells, including self-reactive B cells, thereby reducing autoantibody production and preventing downstream tissue damage.
See More
Previous Close:
$19.26
Open:
$19.42
24h Volume:
948.21K
Relative Volume:
0.82
Market Cap:
$1.05B
Revenue:
-
Net Income/Loss:
$-883.08M
P/E Ratio:
-0.0583
EPS:
-333.4782
Net Cash Flow:
$-150.65M
1W Performance:
+11.40%
1M Performance:
+20.75%
6M Performance:
+31.71%
1Y Performance:
-55.82%
1-Day Range:
$19.41
$20.74
1-Week Range:
$17.28
$20.74
52-Week Range:
$6.50
$53.00
Vor Biopharma Inc Stock (VOR) Company Profile
Name
Vor Biopharma Inc
Sector
Industry
Phone
617-655-6580
Address
500 BOYLSTON STREET, BOSTON
Compare VOR vs VRTX, REGN, ARGX, RVMD, ALNY
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
VOR
Vor Biopharma Inc
|
19.44 | 1.04B | 0 | -883.08M | -150.65M | -333.48 |
VRTX
Vertex Pharmaceuticals Inc
|
479.00 | 121.16B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
667.17 | 68.78B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
888.82 | 57.44B | 4.16B | 1.29B | 734.26M | 19.58 |
RVMD
Revolution Medicines Inc
|
188.07 | 40.23B | 742.00K | -1.37B | -1.07B | -7.0731 |
ALNY
Alnylam Pharmaceuticals Inc
|
278.40 | 36.28B | 4.29B | 577.22M | 641.34M | 4.2086 |
Vor Biopharma Inc Stock (VOR) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Mar-30-26 | Initiated | Jefferies | Buy |
| Mar-19-26 | Initiated | Wells Fargo | Overweight |
| Jan-09-26 | Initiated | Citigroup | Buy |
| Dec-17-25 | Initiated | TD Cowen | Buy |
| Dec-09-25 | Initiated | JP Morgan | Overweight |
| Nov-25-25 | Resumed | Wedbush | Neutral |
| Oct-15-25 | Upgrade | Robert W. Baird | Neutral → Outperform |
| Sep-24-25 | Upgrade | Stifel | Hold → Buy |
| Jun-30-25 | Upgrade | H.C. Wainwright | Neutral → Buy |
| Jul-26-22 | Initiated | Wedbush | Outperform |
| Apr-27-22 | Initiated | Goldman | Neutral |
| Dec-17-21 | Initiated | H.C. Wainwright | Buy |
| Dec-03-21 | Initiated | Robert W. Baird | Outperform |
| Dec-02-21 | Initiated | Oppenheimer | Outperform |
| Oct-19-21 | Initiated | JMP Securities | Mkt Outperform |
| Mar-25-21 | Initiated | B. Riley Securities | Buy |
| Mar-03-21 | Initiated | Barclays | Overweight |
| Mar-03-21 | Initiated | Evercore ISI | Outperform |
| Mar-02-21 | Initiated | Goldman | Sell |
| Mar-02-21 | Initiated | Stifel | Buy |
View All
Vor Biopharma Inc Stock (VOR) Latest News
Vor Biopharma Inc (VOR) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Vor Biopharma Market Sentiment - Benzinga España
Vor Biopharma Inc (VOR) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Vor Biopharma Inc (VOR) Institutional Confidence - TradingKey
Vor Biopharma Inc (VOR) Valuation: PE, PB & Fair Value Analysis - TradingKey
Vor Biopharma Inc (VOR) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
VOR|Vor Biopharma Inc|Price:19.260|Chg%:+0.280 - TradingKey
TradingKey - TradingKey
Vor Biopharma Inc. Revenue Breakdown – NASDAQ:VOR - TradingView
ETFs Investing in Vor Biopharma, Inc. Stocks - TradingView
Ra Capital Management’s fund sells $4,206 in Vor Biopharma stock By Investing.com - Investing.com South Africa
Ra Capital Management’s fund sells $4,206 in Vor Biopharma stock - Investing.com
Form 13D/A VOR BIOPHARMA INC. For: 22 July By Investing.com - Investing.com Nigeria
Form 4 Vor Biopharma Inc For: 22 July By Investing.com - Investing.com Nigeria
RA Capital exercises 2,100,000 Vor Biopharma (VOR) pre-funded warrants - Stock Titan
Vor Biopharma Inc. (VOR) holder exercises 2,100,000 pre-funded warrants - Stock Titan
Price to sales forward of Vor Biopharma Inc. – NASDAQ:VOR - TradingView
Can Vor Biopharma’s (VOR) New Board Appointment Reshape Its Late-Stage Commercialization Strategy? - Sahm
Price to earnings forward of Vor Biopharma Inc. – NASDAQ:VOR - TradingView
Vor Biopharma (VOR) Stock Forum and Discussion - Moomoo
Vor Biopharma Inc. (VOR) Stock Price | Live Quotes & Charts | NASDAQ - timothysykes.com
Form 4 Vor Biopharma Inc For: 9 July By Investing.com - Investing.com Nigeria
Vor Biopharma (VOR) director receives 42,658 stock options at $20.10 strike - Stock Titan
Vor Biopharma (VOR) director submits initial Form 3 with no trades - Stock Titan
Vor Biopharma Inc. Files Form 8-K With SEC – Company Details, Stock Info, and Emerging Growth Status - Minichart
Vor Biopharma Adds Industry Veteran David Zaccardelli to Board - TipRanks
Vor Bio appoints David Zaccardelli to board of directors By Investing.com - Investing.com Canada
David Zaccardelli joins Vor Biopharma (NASDAQ: VOR) board after Levin exit - Stock Titan
Vor Bio Appoints David Zaccardelli to Board of Directors - The Globe and Mail
Vor Biopharma: A Financed Autoimmune Pivot With More Substance Than The Market Realizes - Seeking Alpha
Vor Biopharma Sees Insider Stock Selling - 富途牛牛
Why Vor Biopharma (VOR) Is Up 27.9% After Broad Russell Index Inclusion And What's Next - simplywall.st
Vor Bio Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - Sahm
Vor Bio grants stock awards to 7 new hires under Nasdaq rule - Stock Titan
Why Vor Biopharma (VOR) Is Up 24.5% After Broad FTSE Russell Index Inclusion And What's Next - Yahoo Finance
3 Reasons Vor Biopharma (VOR) Looks Pricey On Russell Index Inclusion - simplywall.st
Vor Biopharma Inc.(NasdaqGS: VOR) added to Russell Small Cap Comp Growth Benchmark - marketscreener.com
Vor Biopharma Inc.(NasdaqGS: VOR) added to Russell 2500 Growth Benchmark - marketscreener.com
Vor Biopharma Inc.(NasdaqGS: VOR) added to Russell 2000 Index - marketscreener.com
Vor Biopharma Inc.(NasdaqGS: VOR) added to Russell 2000 Value Benchmark - marketscreener.com
Vor Biopharma Inc.(NasdaqGS: VOR) added to Russell Microcap Value Benchmark Index - marketscreener.com
Vor Biopharma Inc.(NasdaqGS: VOR) added to Russell Microcap Growth Benchmark Index - marketscreener.com
Vor Biopharma Inc.(NasdaqGS: VOR) added to Russell 2000 Growth Benchmark - marketscreener.com
Vor Biopharma Inc.(NasdaqGS: VOR) added to Russell 3000E Growth Benchmark - marketscreener.com
Vor Biopharma Inc.(NasdaqGS: VOR) added to Russell Microcap Index - marketscreener.com
Vor Biopharma Inc.(NasdaqGS: VOR) added to Russell 3000E Value Benchmark - marketscreener.com
Enterprise value to EBITDA forward of Vor Biopharma Inc. – NASDAQ:VOR - TradingView
Vor Biopharma Inc.(NasdaqGS: VOR) added to Russell 2000 Dynamic Index - marketscreener.com
Enterprise value to EBIT forward of Vor Biopharma Inc. – NASDAQ:VOR - TradingView
Vor Biopharma Q1 2026 Earnings: EPS Misses Estimates by Wide Margin Amid Pre-Revenue Stage - dars.gov.et
Vor Biopharma, Inc. Actuals & Estimates (NASDAQ:VOR) - TradingView
Vor Biopharma Inc Stock (VOR) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.97%
0.83%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):